Local kappa opioid receptor activation decreases temporomandibular joint inflammation. [electronic resource]
Producer: 20120731Description: 371-6 p. digitalISSN:- 1573-2576
- 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer -- administration & dosage
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Cell Movement -- drug effects
- Dose-Response Relationship, Drug
- Formaldehyde
- Inflammation -- drug therapy
- Male
- Naltrexone -- administration & dosage
- Neutrophil Infiltration -- drug effects
- Neutrophils -- physiology
- Rats
- Rats, Wistar
- Receptors, Opioid, kappa -- metabolism
- Temporomandibular Joint -- immunology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.